홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-(2,4-Xylyl)piperazine → [4-(2,4-Dimethylphenyl)piperazin-1-yl][4-(pyrrolidin-1-yl)phenyl]methanone

HRID 2411499
인쇄

반응식

HRID 2411499 반응식
[N:1]1([C:6]2[CH:14]=[CH:13][C:9]([C:10]([OH:12])=O)=[CH:8][CH:7]=2)[CH2:5][CH2:4][CH2:3][CH2:2]1.[CH3:15][C:16]1[CH:21]=[C:20]([CH3:22])[CH:19]=[CH:18][C:17]=1[N:23]1[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]1>>[CH3:15][C:16]1[CH:21]=[C:20]([CH3:22])[CH:19]=[CH:18][C:17]=1[N:23]1[CH2:24][CH2:25][N:26]([C:10]([C:9]2[CH:8]=[CH:7][C:6]([N:1]3[CH2:2][CH2:3][CH2:4][CH2:5]3)=[CH:14][CH:13]=2)=[O:12])[CH2:27][CH2:28]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 705441-(2,4-Xylyl)piperazineHCID 27955154-(Pyrrolidin-1-yl)benzoic acid

생성물 1

HCID 71252121[4-(2,4-Dimethylphenyl)piperazin-1-yl][4-(pyrrolidin-1-yl)phenyl]methanone수율 4.2%

실험 절차

Using 4-(pyrrolidin-1-yl)benzoic acid (200 mg) and 1-(2,4-dimethylphenyl)piperazine (199 mg) and by the reaction and treatment in the same manner as in Example 87, the title compound (15.8 mg) was obtained.

후처리

  1. customby the reaction and treatment in the same manner as in Example 87

출처 및 근거

ORD 기록
ord-06aee11632194b10baf74e8845fb4575
출처 데이터셋
uspto-grants-2014_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08816079B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트